The IL-17 pathway-mediated immune cascade response plays a key role in the pathogenesis of psoriasis, e.g., lowering effector IL-17C expression reduces infiltrating immune cells and thus inhibits skin inflammation [33,34]. This evidence concerns the gene IL17C and psoriasis.